Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Development of inactivated heartwater (Ehrlichia ruminantium) vaccine in South Africa.

Authors:
L C Molepo B Byrom B Weyers N Abdelatif S M Mahan M J Burridge A F Barbet A A Latif

Ticks Tick Borne Dis 2022 05 20;13(3):101942. Epub 2022 Mar 20.

Agricultural Research Council-Onderstepoort Veterinary Research, Onderstepoort, Pretoria, 0110, South Africa; School of Life Sciences, University of KwaZulu-Natal, Durban, Westville, 4001, South Africa. Electronic address:

Heartwater, Ehrlichia ruminantium infection in cattle, sheep, goats, and some wild ruminants, is an economically important disease in Africa characterized by high mortality rates in susceptible populations. In South Africa, the current commercial heartwater vaccine is an infection and treatment type of immunization using virulent live E. ruminantium organisms generated from blood of infected sheep with subsequent treatment of the animals with antibiotics at specific times during the course of infection. This vaccine has several inherent problems preventing its wide use as the vaccine must be administered intravenously and it does not protect against all the South African field isolates. A vaccine based on inactivation of Zimbabwean E. ruminantium Mbizi strain organisms produced in endothelial cell cultures can be a sustainable option because it will not require antibiotic treatment and will be safe as there is no potential for reversion to virulence. Previous data generated in laboratory trials and under natural field setting provides support for this vaccine approach. Four inactivated vaccine formulations using the E. ruminantium Mbizi strain were tested for their efficacy in Merino sheep compared to an unvaccinated control group (11 sheep per group). Two vaccines were prepared by beta-propiolactone (BPL) inactivation, and two were inactivated with binary ethylenimine (BEI) while purification was done with both percoll and polyethylene glycol (PEG). The four vaccine preparations were formulated with Montanide ISA 50V2 adjuvant and administered twice subcutaneously (2 ml per dose) at an interval of 4 weeks. All groups were challenged with a virulent homologous cell-cultured E. ruminantium inoculated via the intra-venous route on day 56. The primary variable of efficacy was measured by the percentage survival rate or mortality between the Controls and Vaccine Groups. Three vaccine formulations (BEI/Percoll (Group 3), BEI/PEG (Group 4), BPL/Percoll, (Group 1) had a significantly higher percent of animal surviving challenge compared to the unvaccinated control (p-values 0.001, 0.035, 0.030, respectively). The highest number of survivors was obtained in Group 3 BEI/Percoll; 10/11 (91%). Groups 4 (BEI/PEG) and Group 1 (BPL/Percoll) produced similar percentage of survivals of 64%. In contrast, the lowest survival rate of 50% was observed in Group 2 (BPL/PEG) which was numerically different but not significantly different from the unvaccinated control which had an 18% survival rate (2/11). The inactivated vaccine using BEI or BPL as inactivating agents blended with ISA 50 adjuvant induced protective immunity against challenge. The BEI/Percoll (Group 3) vaccination regimen was most efficacious against a lethal heartwater challenge as it significantly protected sheep against mortality which is the most important aspect of heartwater infections. Future work should be directed towards improvement of this vaccine formulation especially from the down-stream processing point of view as the percoll method is not scalable for commercialization purposes.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ttbdis.2022.101942DOI Listing
May 2022

Publication Analysis

Top Keywords

unvaccinated control
12
survival rate
12
vaccine
12
group
9
bei/peg group
8
vaccine formulations
8
group bpl/percoll
8
ruminantium mbizi
8
compared unvaccinated
8
south africa
8
mbizi strain
8
inactivated vaccine
8
ehrlichia ruminantium
8
bei/percoll group
8
heartwater ehrlichia
8
ruminantium
6
heartwater
5
sheep
5
2 ml dose
4
dose interval
4

Keyword Occurance

Similar Publications

Characteristics and treatment of hospitalized pregnant women with Coronavirus Disease 2019, COVID-19.

Authors:
Ahlia Sekkarie Rebecca Woodruff Michael Whitaker Michael R Kramer Lauren B Zapata Sascha R Ellington Dana M Meaney-Delman Huong Pham Kadam Patel Christopher A Taylor Shua J Chai Breanna Kawasaki James Meek Kyle P Openo Andy Weigel Lauren Leegwater Kathryn Como-Sabetti Susan L Ropp Alison Muse Nancy M Bennett Laurie M Billing Melissa Sutton H Keipp Talbot Mary Hill Fiona P Havers

Am J Obstet Gynecol MFM 2022 Aug 12:100715. Epub 2022 Aug 12.

Coronavirus Disease-2019 Response Team, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Atlanta, GA 30329; United States Public Health Service Commissioned Corps, Rockville, MD.

Background: Pregnant women less frequently receive Coronavirus Disease 2019 (COVID-19) vaccination and are at increased risk for adverse pregnancy outcomes from COVID-19.

Objectives: First, describe the vaccination status, treatment, and outcomes of hospitalized, symptomatic pregnant women with COVID-19 and second, estimate whether treatment differs by pregnancy status among treatment-eligible (i.e. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Vaccination against COVID-19 reduces virus-related fears: Findings from a German longitudinal study.

Authors:
Daniel Seddig Dina Maskileyson Eldad Davidov

Front Public Health 2022 28;10:878787. Epub 2022 Jul 28.

Faculty of Management, Economics and Social Sciences, Institute of Sociology and Social Psychology, University of Cologne, Cologne, Germany.

During the recent pandemic, fear of COVID-19 has been widespread and is considered to deteriorate mental health. We assessed whether vaccination can effectively reduce the fear of COVID-19 and, thus, contribute to improving people's mental health status. We used two-wave panel data from a German online study collected in April 2021 (t1) and August/September 2021 (t2) and estimated differences-in-differences to determine whether those who were vaccinated against COVID-19 experienced a reduction of fear of COVID-19, and whether the reduction was more evident as compared to people who were not vaccinated for various reasons. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

COVID-19 health practices and attitudes in the United States: the role of trust in healthcare.

Authors:
Jennifer Tabler Jamie A Snyder Clair White Adrienne Freng Linda Thunström

Z Gesundh Wiss 2022 Aug 6:1-14. Epub 2022 Aug 6.

Department of Economics, University of Wyoming, Laramie, WY USA.

Aim: Individual-level COVID-19 vaccination and related preventive health behaviors is politically polarized in the United States. We examined whether the current polarization in COVID-19 health behavior may be explained by differences in trust in healthcare, locus of control, or insurance status.

Subject And Methods: Our sample includes 553 US adults recruited on Amazon MTurk. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Safety of COVID-19 vaccines in pregnancy: a Canadian National Vaccine Safety (CANVAS) network cohort study.

Authors:
Manish Sadarangani Phyumar Soe Hennady P Shulha Louis Valiquette Otto G Vanderkooi James D Kellner Matthew P Muller Karina A Top Jennifer E Isenor Allison McGeer Mike Irvine Gaston De Serres Kimberly Marty Julie A Bettinger

Lancet Infect Dis 2022 Aug 11. Epub 2022 Aug 11.

Vaccine Evaluation Center, BC Children's Hospital Research Institute, Vancouver, BC, Canada; Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada.

Background: Pregnant individuals have been receiving COVID-19 vaccines following pre-authorisation clinical trials in non-pregnant people. This study aimed to determine the frequency and nature of significant health events among pregnant females after COVID-19 vaccination, compared with unvaccinated pregnant controls and vaccinated non-pregnant individuals.

Methods: We did an observational cohort study, set in seven Canadian provinces and territories including Ontario, Quebec, British Columbia, Alberta, Nova Scotia, Yukon, and Prince Edward Island. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

LEGAL AND SOCIAL CHALLENGES OF COVID-19 VACCINATION BEFORE AND AFTER THE 2022 RUSSIAN INVASION OF UKRAINE.

Authors:
Nataliya Gutorova Andrii Lapkin Daryna Yevtieieva

Wiad Lek 2022 ;75(6):1699-1704

АCADEMICIAN STASHIS SCIENTIFIC RESEARCH INSTITUTE FOR THE STUDY OF CRIME PROBLEMS OF THE NATIONAL ACADEMY OF LEGAL SCIENCES OF UKRAINE, KHARKIV, UKRAINE.

Objective: The aim: The study aims to develop ways of solving the social and legal problems of vaccination against COVID-19, showing them the example of Ukraine before and after the beginning of the active phase of Russian aggression.

Patients And Methods: Materials and methods: The study is based on international documents and legal acts adopted to combat the COVID-19 epidemic, the survey results of 165 ordinary Ukrainians on vaccination, interviewing health care organizers; statistical information, and content analysis of the media on vaccination, as well as ways of avoiding it. Dialectical, analytical-synthetic, system-structural methods, as well as methods of content analysis, questionnaires, interviews, and included observation, were used. Read More

View Article and Full-Text PDF
August 2022
Similar Publications
}
© 2022 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap